Clinical Trial Update: The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating tailored eradication therapy for clarithromycin-resistant Helicobacter pylori in peptic ulcer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: Peptic Ulcer | Phase 4 | Status: COMPLETED